News with Multimedia
-
CAI任命Sheena Dempsey為執行長
10/03/2024 - 05:14 AM
-
CAI ernennt Sheena Dempsey zum Chief Executive Officer
10/03/2024 - 05:14 AM
-
CAI任命Sheena Dempsey为首席执行官
10/03/2024 - 05:14 AM
-
CAI、最高経営責任者にシーナ・デンプシーを採用
10/03/2024 - 05:13 AM
-
CAI nomina Sheena Dempsey Amministratrice delegata
10/03/2024 - 05:13 AM
-
CAI benoemt Sheena Dempsey tot Chief Executive Officer
10/03/2024 - 05:13 AM
-
Une filiale d'ImmunoPrecise signe un accord de transfert de matériel avec Biotheus
10/03/2024 - 02:06 AM
-
CAI nombra a Sheena Dempsey consejera delegada
10/02/2024 - 11:36 PM
-
CAI nomme Sheena Dempsey au poste de CEO
10/02/2024 - 11:36 PM
-
Resumen: Novaliq y Laboratoires Théa anuncian su asociación y la aprobación en la UE de Vevizye® (ciclosporina 0,1 % solución colirio)
10/02/2024 - 11:24 PM
-
TXOne Networks Expands Edge Series of OT-Native Network Security Appliances
10/02/2024 - 10:00 PM
-
Options Technology Redefines Market Data Transparency with the Launch of its Atlas Product Suite
10/02/2024 - 08:28 PM
-
Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)
10/02/2024 - 08:00 PM
-
CAI Appoints Sheena Dempsey as Chief Executive Officer
10/02/2024 - 08:00 PM
-
ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
10/02/2024 - 08:00 PM